Products - Chronic obstructive pulmonary disease | Topic | NICE

Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Showing 30 products

Date | Title

Digital technologies to support self-management of COPD: early value assessment (HTE19)
Product type:
Guidance
Programme:
Health technology evaluation
Last updated:
4 February 2025
Published:
19 December 2024
Digital technologies to deliver pulmonary rehabilitation programmes for adults with COPD: early value assessment (HTE18)
Product type:
Guidance
Programme:
Health technology evaluation
Published:
30 April 2024
Human alpha1-proteinase inhibitor for treating emphysema (terminated appraisal) (TA965)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
28 March 2024
Endobronchial nerve ablation for chronic obstructive pulmonary disease (IPG714)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
15 December 2021
Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s (NG202)
Product type:
Guidance
Programme:
NICE guideline
Published:
20 August 2021
Ex-situ machine perfusion for extracorporeal preservation of lungs (ex-vivo lung perfusion) for transplant (IPG695)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
26 May 2021
Electrical stimulation to improve muscle strength in chronic respiratory conditions, chronic heart failure and chronic kidney disease (IPG677)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
5 August 2020
Chronic obstructive pulmonary disease in over 16s: diagnosis and management (NG115)
Product type:
Guidance
Programme:
NICE guideline
Last updated:
26 July 2019
Published:
5 December 2018
Bronchoscopic thermal vapour ablation for upper-lobe emphysema (IPG652)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
12 June 2019
Chronic obstructive pulmonary disease (acute exacerbation): antimicrobial prescribing (NG114)
Product type:
Guidance
Programme:
NICE guideline
Published:
5 December 2018
Endobronchial valve insertion to reduce lung volume in emphysema (IPG600)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
20 December 2017
Roflumilast for treating chronic obstructive pulmonary disease (TA461)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published:
26 July 2017
Insertion of endobronchial nitinol coils to improve lung function in emphysema (IPG517)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
27 March 2015
Lung volume reduction surgery for advanced emphysema (IPG114)
Product type:
Guidance
Programme:
Interventional procedures guidance
Published:
23 February 2005
FreeO2 automatic oxygen titration for chronic obstructive pulmonary disease and respiratory distress syndrome (MIB281)
Product type:
Advice
Programme:
Medtech innovation briefing
Published:
7 December 2021
Artificial intelligence for analysing chest CT images (MIB243)
Product type:
Advice
Programme:
Medtech innovation briefing
Published:
5 January 2021
myAIRVO2 for the treatment of chronic obstructive pulmonary disease (MIB161)
Product type:
Advice
Programme:
Medtech innovation briefing
Published:
1 October 2018
OxyMask for delivering oxygen therapy (MIB160)
Product type:
Advice
Programme:
Medtech innovation briefing
Published:
27 September 2018
VIDAvision for lung volume analysis in emphysema (MIB148)
Product type:
Advice
Programme:
Medtech innovation briefing
Published:
5 June 2018
Chronic obstructive pulmonary disease in adults (QS10)
Product type:
Quality standard
Last updated:
19 September 2023
Published:
28 July 2011
Mepolizumab for reducing eosinophilic exacerbations of chronic obstructive pulmonary disease [ID1237]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Balloon dilation plus spiculiform electrosurgery towards the therapy of obstructive Airway Disease: Central Airway Fibrotic Stricture - benign
Status:
Topic selection
Programme:
Interventional procedures guidance
Expected publication date:
TBC
Dupilumab for treating moderate to severe chronic obstructive pulmonary disease ID6235
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Use of a glue or sealant to achieve lung volume reduction in emphysema and lung cancer
Status:
Topic selection
Programme:
Interventional procedures guidance
Expected publication date:
TBC
Bronchoscopic intrabullous autologous blood instillation (BIABI) for the therapy of Emphysema: intractable with pneumothorax, COPD & Lung cancer, patients requiring lung biopsy
Status:
Topic selection
Programme:
Interventional procedures guidance
Expected publication date:
TBC
MT633 FreeO2 Automatic Oxygen Titration
Status:
Topic selection
Programme:
Medical technologies guidance
Expected publication date:
TBC
RespiraSense (MT736)
Status:
Topic selection
Programme:
Medical technologies guidance
Expected publication date:
TBC
Astegolimab as add-on maintenance treatment for moderate to severe chronic obstructive pulmonary disease [ID6524]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Mepolizumab for treating chronic obstructive pulmonary disease with eosinophil-associated exacerbations TSID12019
Status:
Topic selection
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Itepekimab as add-on maintenance treatment for moderate to severe chronic obstructive pulmonary disease [ID6547]
Status:
Awaiting development
Programme:
Technology appraisal guidance
Expected publication date:
TBC